Vital update for Valneva’s COVID-19 vaccine
2nd March 2023 Uncategorised 0European Medicines Agency has issued a positive opinion for the use of VLA2001 among certain adults More: Vital update for Valneva’s COVID-19 vaccine Source: News
read more
European Medicines Agency has issued a positive opinion for the use of VLA2001 among certain adults More: Vital update for Valneva’s COVID-19 vaccine Source: News
read moreCandidate POLB 001 demonstrates potential in treating multiple influenza conditions More: Positive results from Poolbeg Pharma’s human challenge trial Source: News
read moreRoche sues Biogen over royalties related to multiple sclerosis drug Tysabri kdunleavy Wed, 03/01/2023 – 16:25 More: Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri Source: fierce
read moreICER dials up recommended price range for Eisai’s Leqembi—but still calls for sizable discount aliu Wed, 03/01/2023 – 14:01 More: ICER dials up recommended price range for Eisai's Leqembi—but still calls for sizable discount Source: fierce
read moreJohnson & Johnson logs 57 layoffs in Pennsylvania as Kenvue spinoff nears fkansteiner Wed, 03/01/2023 – 13:36 More: Johnson & Johnson logs 57 layoffs in Pennsylvania as Kenvue spinoff nears Source: fierce
read moreRegeneron, Sanofi’s Kevzara becomes first biologic approved for polymyalgia rheumatica zbecker Wed, 03/01/2023 – 10:46 More: Regeneron, Sanofi's Kevzara becomes first biologic approved for polymyalgia rheumatica Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals